Gilead Sciences (GILD) Tops Q2 EPS by 44c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $135.82 --0%
EPS Growth %: -464.2%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: -464.2%
Financial Fact:
Interest expense: -242M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $3.15, $0.44 better than the analyst estimate of $2.71. Revenue for the quarter came in at $8.24 billion versus the consensus estimate of $7.61 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Gilead Sciences (GILD) to Buy
- PepsiCo (PEP) Misses Q2 EPS by 1c, Beats on Revenue
- Kepler Cheuvreux Starts elementis Plc (ELM:LN) (ELMTY) at Buy
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
